Glipizide
Glipizide is an oral medium-to-long acting anti-diabetic drug from the sulfonylurea class.
It is available under the brand name Glucotrol by Pfizer, originally available in 1984. Pfizer sells Glucotrol in doses of 5 and 10 milligrams and Glucotrol XL (an extended release form of glipizide) in doses of 2.5, 5, and 10 milligrams. Other companies sell generic forms of glipizide, most commonly extended release tablets of 5 and 10 milligrams.